Mississippi
CNS clinical trials in Mississippi
29 CNS studies are recruiting participants at sites in 11 cities across Mississippi as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Mississippi city with a recruiting study
By research area: Depression (7), Migraine (7), Schizophrenia (5), ADHD (4), Parkinson's Disease (4), Bipolar Disorder (2).
Flowood (14), Jackson (6), Ridgeland (6), Gulfport (2), Hattiesburg (2), Brooklyn (1), Columbus (1), Grenada (1), New Albany (1), Oxford (1), Southhaven (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Mississippi
Basic details from each study's public record (the 12 most recently updated of 29). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Flowood
- Registry record
- NCT07226661 · updated
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Recruiting in
- Flowood
- Registry record
- NCT07284667 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Recruiting in
- Flowood
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Columbus · Grenada · Jackson · and 3 more U.S. locations
- Registry record
- NCT06748222 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Brooklyn
- Registry record
- NCT07573176 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Mississippi on ClinicalTrials.gov.
Bipolar disorder: recently updated in Mississippi
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Flowood
- Registry record
- NCT06951711 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Mississippi on ClinicalTrials.gov.
ADHD: recently updated in Mississippi
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Jackson
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Jackson
- Registry record
- NCT07717892 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Mississippi on ClinicalTrials.gov.
Parkinson's disease: recently updated in Mississippi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Jackson
- Registry record
- NCT06989112 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Hattiesburg
- Registry record
- NCT06841354 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Jackson
- Registry record
- NCT06952504 · updated
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Hattiesburg
- Registry record
- NCT06170788 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Mississippi on ClinicalTrials.gov.
Ask about studies in Mississippi
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections